4 high-growth dividend champions
Over the last few months I’ve mostly written about high yield stocks and the occasional high-profile disaster. That sort of…
7 years ago
John Kingham
Can a 15% dividend yield ever be sustainable?
Very few stocks ever have a dividend yield of 15% or more, and if they do then the dividend has…
7 years ago
Who will be the next Carillion?
For many dividend investors, the demise of Carillion was a disaster. Not only did their portfolios lose an important source…
7 years ago
Is Buffett right to choose Coca Cola over Microsoft?
As a UK investor I am mostly interested in UK stocks. However, Master Investor’s focus last month on the US…
7 years ago
Unearthing bargains among high-yield stocks
Every now and then I like to take a look at the highest yielding stocks in the market. Not to…
7 years ago
Bag a premium income from the insurance majors
As dividend stocks go, life insurance companies have a mixed track record. On the one hand, they operate in a…
7 years ago
What you need to know to avoid the next Carillion
Following its demerger from Tarmac Group in 1999, Carillion has given its shareholders fantastic returns year after year. Perhaps the…
7 years ago
Was Woodford right to sell Glaxo and hold AstraZeneca?
AstraZeneca (LON:AZN) and GlaxoSmithKline (LON:GSK) are the two pharmaceutical giants of the FTSE 100. They are also both high yield…
7 years ago
This FTSE 250 company yields close to 7% – but is it a yield trap?
Over the last two of month's I've outlined a series of ten questions which I use to help me avoid…
8 years ago
How to avoid yield traps – Part 1
As a dividend-focused investor I’m always on the lookout for high yield shares, whether that yield is high relative to…
8 years ago